Innovating Works

SightLeaders

Financiado
StemSight: curing blindness with stem cells
StemSight is developing off-the-shelf stem cell therapies to cure blindness. We aim to solve the global shortage of corneal donor tissue by producing high-quality tissue products using allogeneic induced pluripotent stem cells (iP... StemSight is developing off-the-shelf stem cell therapies to cure blindness. We aim to solve the global shortage of corneal donor tissue by producing high-quality tissue products using allogeneic induced pluripotent stem cells (iPSCs) and biomaterials. Our lead product is aimed at a rare but severe form of corneal blindness, limbal stem cell deficiency (LSCD), for which there are currently no valid treatment options. The company's innovations have arisen from extensive academic research, and the company has spun out from Tampere University, Finland in 2021. StemSight is a rare kind of deep-tech startup, as all of its scientific founders are women. ver más
31/05/2024
75K€
Duración del proyecto: 12 meses Fecha Inicio: 2023-05-26
Fecha Fin: 2024-05-31

Línea de financiación: concedida

El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-05-31
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
HORIZON-EIE-2022-SCALEUP-02-02: Women TechEU
Cerrada hace 2 años
Presupuesto El presupuesto total del proyecto asciende a 75K€
Líder del proyecto
STEMSIGHT OY No se ha especificado una descripción o un objeto social para esta compañía.